Rapid and Ultrasensitive CRISPR-SERS Biosensing of Circulating Tumor Cell mRNAs for Molecular Metastatic Risk Assessment
Analytical Chemistry · 18.11.2026
DOI: 10.1021/acs.analchem.6c06668 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 18.11.2026. Verfasst von Hao Li und 5 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, Jiangsu Funding Program for Excellent Postdoctoral Talent, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Metastatic recurrence remains a major cause of poor prognosis in hepatocellular carcinoma (HCC), yet sensitive molecular assessment of metastatic risk is still limited. Circulating tumor cell (CTC)-derived transcripts offer a direct readout of tumor dissemination programs, but their rapid multiplex analysis remains challenging because of low-input rare-cell samples, low transcript abundance, and handling-associated molecular loss. Here, we report the Flexible LAMP-assisted Raman-CRISPR Engine for CTC mRNA analysis (FLARE-CTC) for multiplex transcript profiling and molecular metastatic risk assessment in HCC. Built on a flexible hierarchical surface-enhanced Raman scattering interface fabricated by a reverse-assembly peel-off transfer process, FLARE-CTC integrated rapid isothermal amplification, CRISPR-Cas12a recognition, and single-stranded DNA linker-mediated Raman-active nanoprobes to establish an anchoring-to-release Raman readout. Following CTC enrichment and on-chip lysis, this design enabled parallel quantification of seven HCC CTC-associated transcripts and β-actin within 30 min at attomolar-level sensitivity. In 58 clinical samples, integrated HCC identity-related transcripts distinguished HCC patients from healthy controls with an AUC of 0.972. Further integration of epithelial-mesenchymal transition- and stemness-associated transcripts generated a metastasis score that assessed metastatic risk with an AUC of 0.892, sensitivity of 0.947, and specificity of 0.857. A two-dimensional risk map combining diagnostic and metastatic scores further visualized patient-level molecular heterogeneity and identified imaging-negative individuals with high-risk molecular profiles. Overall, FLARE-CTC provides a rapid, ultrasensitive, and scalable biosensing strategy for multiplex CTC mRNA analysis and molecular metastatic risk assessment in HCC.
Förderung
- Natural Science Foundation of the Higher Education Institutions of Jiangsu Province
- Jiangsu Funding Program for Excellent Postdoctoral Talent
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Beijing Bethune Charitable Foundation
- Jiangsu Province Seventh 333 High-Level Talents Project
- Suzhou Science and Technology Development Plan Project
- Suzhou Science and Technology Development Plan
Zitieren
APA
Li, H., Xia, R., Li, W., Han, X., Sun, J., & Zhu, H. (2026). Rapid and Ultrasensitive CRISPR-SERS Biosensing of Circulating Tumor Cell mRNAs for Molecular Metastatic Risk Assessment. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c06668
Vancouver
Li H, Xia R, Li W, Han X, Sun J, Zhu H. Rapid and Ultrasensitive CRISPR-SERS Biosensing of Circulating Tumor Cell mRNAs for Molecular Metastatic Risk Assessment. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c06668
BibTeX
@article{Li2026,
author = {Li, Hao and Xia, Rongrong and Li, Wei and Han, Xin and Sun, Jiaojiao and Zhu, Hong},
title = {Rapid and Ultrasensitive CRISPR-SERS Biosensing of Circulating Tumor Cell mRNAs for Molecular Metastatic Risk Assessment},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c06668}
}
EUVIMED